Volume 65, Issue 3, Pages (March 2014)

Slides:



Advertisements
Similar presentations
The PSA Era is not Over for Prostate Cancer
Advertisements

Volume 69, Issue 3, Pages (March 2016)
Volume 57, Issue 1, Pages (January 2010)
Volume 50, Issue 1, Pages (July 2006)
Volume 60, Issue 2, Pages (August 2011)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Testosterone Therapy in Men With Prostate Cancer
Volume 62, Issue 5, Pages (November 2012)
Volume 61, Issue 6, Pages (June 2012)
Volume 62, Issue 5, Pages (November 2012)
Volume 64, Issue 6, Pages (December 2013)
Volume 70, Issue 1, Pages (July 2016)
Volume 69, Issue 2, Pages (February 2016)
Association between Smoking, Passive Smoking, and Erectile Dysfunction: Results from the Boston Area Community Health (BACH) Survey  Varant Kupelian,
Volume 67, Issue 3, Pages (March 2015)
Volume 53, Issue 5, Pages (May 2008)
Prostate Cancer Epidemic in Sight?
Volume 66, Issue 1, Pages (July 2014)
John P. Mulhall, Francesco Montorsi  European Urology 
Volume 69, Issue 2, Pages (February 2016)
Volume 63, Issue 1, Pages (January 2013)
Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey  John B. McKinlay, Carol L. Link  European.
Volume 74, Issue 4, Pages (October 2018)
Volume 52, Issue 5, Pages (November 2007)
Volume 69, Issue 3, Pages (March 2016)
Prostate Cancer Detection: A View of the Future
Volume 67, Issue 3, Pages (March 2015)
Volume 69, Issue 6, Pages (June 2016)
Volume 69, Issue 3, Pages (March 2016)
Volume 60, Issue 4, Pages (October 2011)
Laurent Boccon-Gibod  European Urology Supplements 
Volume 73, Issue 2, Pages (February 2018)
Prostate Cancer Epidemic in Sight?
The PSA Era is not Over for Prostate Cancer
Yuanshan Cui, Yong Zhang  European Urology 
Global Burden of Urologic Cancers, 1990–2013
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 61, Issue 6, Pages (June 2012)
Volume 68, Issue 6, Pages (December 2015)
Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward?  Michel Bolla  European.
Tillmann Loch, Pat Fox Fulgham  European Urology 
Volume 68, Issue 4, Pages (October 2015)
Richard C. Harkaway  European Urology Supplements 
Volume 50, Issue 3, Pages (September 2006)
Volume 50, Issue 5, Pages (November 2006)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 55, Issue 3, Pages (March 2009)
Bone Health in Patients With Prostate Cancer: Monitoring and Diagnosis
Testicular Cancer Variations in Time and Space in Europe
Insights into the Relationships between Prostatic Disorders and Their Potential Impact on Future Urologic Practice  Claus Roehrborn  European Urology.
Volume 54, Issue 6, Pages (December 2008)
Volume 75, Issue 4, Pages (April 2019)
Volume 72, Issue 2, Pages (August 2017)
Volume 59, Issue 4, Pages (April 2011)
European Urology is “Your” Journal
Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.
How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia?  Vincenzo Mirone 
Axel Heidenreich  European Urology Supplements 
Economic Burden of Bladder Cancer Across the European Union
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson 
Volume 53, Issue 2, Pages (February 2008)
Manfred Wirth, Peter Iversen, David McLeod, William See 
Oncoforum Urology: Prostate Cancer 2008 at a Glance
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Axel Heidenreich  European Urology Supplements 
Volume 51, Issue 5, Pages (May 2007)
Salvage Local Treatments After Focal Therapy for Prostate Cancer
Introduction European Urology Supplements
European Urology Oncology
Presentation transcript:

Volume 65, Issue 3, Pages 512-515 (March 2014) A Progress Report on a Prospective Randomised Trial of Open and Robotic Prostatectomy  Robert A. Gardiner, Geoffrey D. Coughlin, John W. Yaxley, Nigel T. Dunglison, Stefano Occhipinti, Sandra J. Younie, Rob C. Carter, Scott G. Williams, Robyn J. Medcraft, Hema M. Samaratunga, Joanna L. Perry-Keene, Diane J. Payton, Martin F. Lavin, Suzanne K. Chambers  European Urology  Volume 65, Issue 3, Pages 512-515 (March 2014) DOI: 10.1016/j.eururo.2013.10.031 Copyright © 2013 Terms and Conditions

Fig. 1 Strategic Research Programme trial protocol. Abdo=abdomen; ACE 27=Adult Comorbidity Evaluation-27; ADT=androgen deprivation therapy; Anaes=anaesthetic; BMI=body mass index; CT=computed tomography; ECG=electrocardiogram; EPIC=Expanded Prostate Cancer Index Composite; ePSA=equimolar prostate-specific antigen; HADS=Hospital Anxiety and Depression Scale; Histol=histology; IES=Impact of Event Scale; IIEF=International Index of Erectile Function; IPSS=International Prostate Symptom Score; mpMRI=multiparametric magnetic resonance imaging; MSU=midstream specimen of urine; OT=operating theatre; Postop=postoperative; QoL=quality of life; RPP=radical prostatectomy pathology; SHIM=Sexual Health Inventory for Men; TIBI-CaP=total illness burden index for prostate cancer; TRUS=transrectal ultrasound. European Urology 2014 65, 512-515DOI: (10.1016/j.eururo.2013.10.031) Copyright © 2013 Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.